Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

LTGO Net Debt

Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.

No reported Net Debt figures are available to summarize.

Net Debt history

Currency unavailable · from the balance sheet

No Net Debt data reported for this period type.

Net Debt vs competitors

How LTGO compares with its peers on the latest reported figures

LTGO Competitors
Net Debt for LTGO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
COLLCollegium Pharmaceutical, Inc.Mar 2026$539.41M USD-27.9%+8.8%32.7%
PCRXPacira BioSciences, Inc.Mar 2026$266.87M USD-24.4%-23.4%22.1%
SCLXScilex Holding CompanyMar 2026$103.01M USD+188.5%—35.1%
LTGOLatigo Biotherapeutics Inc.—— ———
Peer median (excluding LTGO) —-24.4%-7.3%32.7%

Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Intrinsic Alpha fair value

Locked

Current Price

$13.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.